MaxCyte Cell & Gene Tech Expo April 2025: Cell Therapy

MaxCyte® is a leading cell-engineering company driving the discovery, development, and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQure Dx™ gene editing risk assessment services enable precise, efficient, and scalable cell engineering. Supported by expert scientific, technical, and regulatory guidance, MaxCyte’s platform empowers researchers to engineer diverse cell types and payloads, accelerating the development of safe, effective treatments. For over 25 years, we’ve been advancing cell engineering, shaping the future of medicine. Let’s Build Better Cells Together.™